Fertility Futility: Procedures Claimed to Boost IVF Success Lack Supporting Evidence
By Sandy Ong,
Newsweek
| 01. 12. 2017
Natalie Fitzpatrick, 29, had been through three rounds of in vitro fertilization when her doctors suggested she try immunotherapy. Each of her IVF treatments had resulted in a miscarriage, and her doctors wanted to test her to see if there was something wrong with her immune system. But nearly $4,000 later, the additional testing proved fruitless. Fitzpatrick’s next two IVF cycles were unsuccessful—she miscarried once more—and she’s still trying.
Testing the immune system is one of a growing number of additional services offered to couples who can’t conceive through IVF treatment alone. Some clinics say they do it because certain antibodies can interfere with embryo implantation, but these claims are not backed by evidence. According to a study that appeared in the BMJ at the end of November, the same is true for many other extra services—of nearly 30 fertility clinic add-ons reviewed, only one increased a woman’s chances of having a baby. That was an endometrial scratch, in which a small nick is made in the uterus’s lining to increase the likelihood of an embryo implanting on it. And...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...